Cargando…

Albumin-Bilirubin (ALBI) and Monocyte to Lymphocyte Ratio (MLR)-Based Nomogram Model to Predict Tumor Recurrence of AFP-Negative Hepatocellular Carcinoma

PURPOSE: In this study, we aimed to develop a novel liver function and inflammatory markers-based nomogram to predict recurrence-free survival (RFS) for AFP-negative (<20 ng/mL) HCC patients after curative resection. PATIENTS AND METHODS: A total of 166 pathologically confirmed AFP-negative HCC p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mao, Shuqi, Yu, Xi, Shan, Yuying, Fan, Rui, Wu, Shengdong, Lu, Caide
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8594894/ https://www.ncbi.nlm.nih.gov/pubmed/34805014 http://dx.doi.org/10.2147/JHC.S339707

Ejemplares similares

Prognostic Prediction for Patients with Hepatocellular Carcinoma and Ascites: Role of Albumin-Bilirubin (ALBI) Grade and Easy (EZ)-ALBI Grade
por: Liao, Jia-I, et al.
Publicado: (2023)

Nomogram for the Preoperative Prediction of the Macrotrabecular-Massive Subtype of Hepatocellular Carcinoma
por: Shan, Yuying, et al.
Publicado: (2022)

Preoperative nomogram for microvascular invasion prediction based on clinical database in hepatocellular carcinoma
por: Mao, Shuqi, et al.
Publicado: (2021)

Author Correction: Preoperative nomogram for microvascular invasion prediction based on clinical database in hepatocellular carcinoma
por: Mao, Shuqi, et al.
Publicado: (2021)

Prognostic Role of Albumin, Bilirubin, and ALBI Scores: Analysis of 1000 Patients with Hepatocellular Carcinoma Undergoing Radioembolization
por: Antkowiak, Mark, et al.
Publicado: (2019)

Proton Beam Therapy for Treatment-Naïve Hepatocellular Carcinoma and Prognostic Significance of Albumin-Bilirubin (ALBI) Grade
por: Kim, Tae Hyun, et al.
Publicado: (2022)

To determine the prognostic value of the albumin–bilirubin grade (ALBI) in patients underwent transarterial chemoembolization for unresectable hepatocellular carcinoma
por: Khalid, Muhammad Ali, et al.
Publicado: (2019)

The Association of Albumin-Bilirubin (ALBI) Grade with Mortality Risk in Trauma Patients with Liver Injuries
por: Chou, Sheng-En, et al.
Publicado: (2023)

Development of nomogram models of inflammatory markers based on clinical database to predict prognosis for hepatocellular carcinoma after surgical resection
por: Mao, Shuqi, et al.
Publicado: (2022)

Comparison of platelet-albumin-bilirubin (PALBI), albumin-bilirubin (ALBI), and child-pugh (CP) score for predicting of survival in advanced hcc patients receiving radiotherapy (RT)
por: Ho, Connie H.M., et al.
Publicado: (2018)

Albumin-bilirubin (ALBI) score at admission predicts possible outcomes in patients with acute-on-chronic liver failure
por: Chen, Bo, et al.
Publicado: (2017)

Machine learning-based normal tissue complication probability model for predicting albumin-bilirubin (ALBI) grade increase in hepatocellular carcinoma patients
por: Prayongrat, Anussara, et al.
Publicado: (2022)

Comparing various scoring system for predicting overall survival according to treatment modalities in hepatocellular carcinoma focused on Platelet-albumin-bilirubin (PALBI) and albumin-bilirubin (ALBI) grade: A nationwide cohort study
por: Lee, Soon Kyu, et al.
Publicado: (2019)

Neutrophil to lymphocyte ratio and albumin bilirubin grade in hepatocellular carcinoma: A systematic review
por: Bannaga, Ayman, et al.
Publicado: (2020)

Development and validation of a nomogram to predict liver metastasis for pancreatic ductal adenocarcinoma after radical resection
por: Tong, Jingshu, et al.
Publicado: (2022)

Neutrophil-to-Lymphocyte Ratio (NLR) and Monocyte-to-Lymphocyte Ratio (MLR) Predict Clinical Outcome in Patients with Stage IIB Cervical Cancer
por: Li, Yong-Xia, et al.
Publicado: (2021)

Macrotrabecular-massive subtype-based nomogram to predict early recurrence of hepatocellular carcinoma after surgery
por: Yang, Yong, et al.
Publicado: (2023)

Combined preoperative albumin-bilirubin (ALBI) and serum γ-glutamyl transpeptidase (GGT) predicts the outcome of hepatocellular carcinoma patients following hepatic resection
por: Zhang, Chi-Hao, et al.
Publicado: (2019)

Correction: Machine learning-based normal tissue complication probability model for predicting albumin-bilirubin (ALBI) grade increase in hepatocellular carcinoma patients
por: Prayongrat, Anussara, et al.
Publicado: (2023)

Albumin - bilirubin (ALBI) versus Child-Turcotte-Pugh (CTP) in prognosis of HCC after stereotactic body radiation therapy
por: Su, Ting-Shi, et al.
Publicado: (2019)

The Predictive Role of Neutrophil-to-Lymphocyte Ratio (NLR), Platelet-to-Lymphocyte Ratio (PLR), Monocytes-to-Lymphocyte Ratio (MLR) and Gammaglobulins for the Development of Cutaneous Vasculitis Lesions in Primary Sjögren’s Syndrome
por: Mihai, Ancuta, et al.
Publicado: (2022)

Development and Validation of a Prognostic Nomogram in AFP-negative hepatocellular carcinoma
por: Wang, Xueping, et al.
Publicado: (2019)

The SAFFO Study: Sex-Related Prognostic Role and Cut-Off Definition of Monocyte-to-Lymphocyte Ratio (MLR) in Metastatic Colorectal Cancer
por: Lisanti, Camilla, et al.
Publicado: (2022)

Bilirubin/Albumin Ratio for Predicting Acute Bilirubin-induced Neurologic Dysfunction
por: Ardakani, Shahin Behjati, et al.
Publicado: (2011)

Comparison of Four Albumin-Based Liver Reserve Models (ALBI/EZ-ALBI/PALBI/PAL) against MELD for Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization
por: Ho, Shu-Yein, et al.
Publicado: (2023)

The Prognostic Significance of Neutrophil to Lymphocyte Ratio (NLR), Monocyte to Lymphocyte Ratio (MLR) and Platelet to Lymphocyte Ratio (PLR) on Long-Term Survival in Off-Pump Coronary Artery Bypass Grafting (OPCAB) Procedures
por: Urbanowicz, Tomasz, et al.
Publicado: (2021)

Association of Postoperative Neutrophil Lymphocyte Ratio (NLR) and Monocyte Lymphocyte Ratio (MLR) with the Presence of Osteoporosis in Japanese Patients after Hip Fracture Surgery: A Retrospective Cohort Study
por: Bekki, Hirofumi, et al.
Publicado: (2021)

Increased serum total bilirubin-albumin ratio was associated with bilirubin encephalopathy in neonates
por: Wang, Yan, et al.
Publicado: (2020)

Combination of neutrophil/lymphocyte ratio and albumin/bilirubin grade as a prognostic predictor for hepatocellular carcinoma patients undergoing curative hepatectomy
por: Luo, Hao, et al.
Publicado: (2023)

Establishment and validation of nomogram model for the diagnosis of AFP-negative hepatocellular carcinoma
por: Liu, Long, et al.
Publicado: (2023)

Prognostic value of pretreatment albumin to bilirubin ratio in patients with hepatocellular cancer: A meta-analysis
por: Xu, Yi-Xin, et al.
Publicado: (2019)

In albis : poemas, 1979-1990 /
por: Magaña, Gabriel, 1944-

Copy number variations of MMP-9 are prognostic biomarkers for hepatocellular carcinoma
por: Yu, Xi, et al.
Publicado: (2020)

Ratio of cord blood bilirubin and albumin as predictors of neonatal hyperbilirubinaemia
por: Sharma, Indra Kumar, et al.
Publicado: (2020)

Preoperative alpha fetoprotein, total bilirubin, fibrinogen, albumin, and lymphocytes predict postoperative survival in hepatocellular carcinoma
por: Xu, Jia, et al.
Publicado: (2023)

Correlation Between Total Bilirubin, Total Bilirubin/Albumin Ratio with Disease Activity in Patients with Rheumatoid Arthritis
por: Zhang, Hui, et al.
Publicado: (2023)

The predictive significance of umbilical cord bilirubin and bilirubin/albumin ratio for neonatal jaundice in healthy term newborns
por: ŞAHAN, Handan, et al.
Publicado: (2022)

Novel prognostic score based on the preoperative total bilirubin-albumin ratio and fibrinogen-albumin ratio in ampullary adenocarcinoma
por: Zhang, Xiao-Jie, et al.
Publicado: (2023)

Preoperative albumin-bilirubin grade plus platelet-to-lymphocyte ratio predict the outcomes of patients with BCLC stage A hepatocellular carcinoma after liver resection
por: Li, Chuan, et al.
Publicado: (2018)

Nomogram Based on Platelet–Albumin–Bilirubin for Predicting Tumor Recurrence After Surgery in Alpha-Fetoprotein-Negative Hepatocellular Carcinoma Patients
por: Yang, Chengkai, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_opccqqr1rhatj47dn5nhe9fg9i